您的位置：网站名称 → 研发专利新闻 → 正文
内容搜索
热门内容
• USPTO issues notice of
• USPTO issues patent to
• Israel grants patent t
• Shire files lawsuit ag
• US District Court rule
• USPTO rejects Biotage'
• U.S. District Court ru
• USPTO issues Notice of
• Medical industry veter
• EPO Board of Appeal re
• U.S. District Court gr
• Acorda receives patent
推荐内容
• MSF letter criticizes
• EPO grants patent to M
• Pro-Pharmaceuticals re
• USPTO grants Cortex pa
• NovaSterilis novel vac
• USPTO issues patent to
• WSU researcher develop
• Watson Laboratories se
• POZEN, AstraZeneca fil
• Salix Pharmaceuticals
• Acorda receives patent
• U.S. District Court gr
最新内容
• MSF letter criticizes
• EPO grants patent to M
• USPTO grants Cortex pa
• NovaSterilis novel vac
• Pro-Pharmaceuticals re
• POZEN, AstraZeneca fil
• USPTO issues patent to
• WSU researcher develop
• Watson Laboratories se
• Salix Pharmaceuticals
• Acorda receives patent
• U.S. District Court gr
反馈意见和建议

NovaSterilis novel vaccine patent
 添加时间:2011-05-15 原文发表:2011-04-26 人气:3

NovaSterilis Inc., a leader in the development and commercialization of supercritical carbon dioxide technology, has been granted US Patent 7,919,096. The patent, dated April 5th 2011, is entitled Inactivating Organisms Using...

查看所有的文章内容需要 VIP会员权限 查看


 
点这里复制本页地址发送给您QQ/MSN上的好友

相关文章
• Pro-Pharmaceuticals receives method pate
• POZEN, AstraZeneca file lawsuit against
• USPTO issues patent to Oragenics ProBior
• WSU researcher develops potential vaccin
• Watson Laboratories seeks FDA approval t
• Salix Pharmaceuticals receives three U.S
• Acorda receives patent for AMPYRA tablet
• U.S. District Court grants preliminary i
• QRxPharma receives new U.S. Patent for M
• EPO grants patent to OncoGenex OGX-427 f
• USPTO grants Cortex patent for CX1739 AM
• EPO grants patent to Microbix' VIRUSMAX
• MSF letter criticizes Johnson & Johnson

相关评论

本文章所属分类：首页 → 研发专利新闻